Tempus AI (TEM) Stock Is Rising Monday: What's Going On?

Tempus AI shares are trading higher Monday morning. The company announced it has received U.S. Food and Drug Administration ...
TMCnet

Tempus Receives U.S. FDA 510(k) Clearance for Tempus xR IVD, its RNA NGS In Vitro Diagnostic Device

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced it has received 510 (k) clearance from the U.S. Food and ...

Tempus AI Surges Since IPO as FDA Clearance Boosts Growth Outlook

On August 08, 2025, Tempus AI, Inc. (NASDAQ:TEM) reported a second-quarter 2025 revenue of $314.6 million, an increase of ...